(1 - 30 von 38
)
Key Neuroscience Insights to Better Understand the ...Belmont Village
www.belmontvillage.com
— Stephen Strittmatter, Director of Yale University School of Medicine's Cellular Neuroscience, Neurodegeneration and Repair Program, in a — Stephen Strittmatter, Director of Yale University School of Medicine's Cellular Neuroscience, Neurodegeneration and Repair Program, in a ...
AMF Alzheimer's Research Lecture Series with Dr. ...Aging Mind Foundation
agingmindfoundation.org
Dr. Stephen Strittmatter Director of Yale University School of Medicine's Cellular Neuroscience, Neurodegeneration and Repair Program Dr. Stephen Strittmatter Director of Yale University School of Medicine's Cellular Neuroscience, Neurodegeneration and Repair Program
LETTER: Yale research model is validNew Haven Register
www.nhregister.com
— As an example, Yale neurologist Stephen Strittmatter has discovered mechanisms that allow nerves to repair themselves -- promoting promising — As an example, Yale neurologist Stephen Strittmatter has discovered mechanisms that allow nerves to repair themselves -- promoting promising ...
New Teams, New ToolsKavli Foundation
kavlifoundation.org
— Incoming Director of the Kavli Institute for Neuroscience at Yale, Stephen Strittmatter looks to the future — Incoming Director of the Kavli Institute for Neuroscience at Yale, Stephen Strittmatter looks to the future.
Newly discovered compound may target Alzheimer'sYale Daily News
yaledailynews.com
— Using this animal model, a research team led by Stephen Strittmatter, School of Medicine professor of neurology and director of the — Using this animal model, a research team led by Stephen Strittmatter, School of Medicine professor of neurology and director of the ...
Yale discovery could lead to Alzheimer’s drug, restored memory – The...
www.denverpost.com
Dr. Stephen Strittmatter, professor of neurology at Yale. By New Haven Register |. PUBLISHED: September 4, at 9:55 am | UPDATED: June 13, at ...
Promising New Tactic Found in Battle Against Alzheimer’s Disease |...
healthland.time.com
After failing to find ways of removing the brain plaques responsible for the disease, researchers now say they have another way of tackling Alzheimer’s worst...
Medizinische Forschung: Auslöser für Alzheimer gefunden
www.handelsblatt.com
Die Forscher um Stephen Strittmatter von der Yale-Universität hatten eine Genexpressions-Analyse durchgeführt, um den Auslöser für ein frühes Symptom der
Medizinische Forschung: Auslöser für Alzheimer gefundenwww.handelsblatt.com › technik › medizin › medizinische-forschung-auslo...
www.handelsblatt.com
· Die Forscher um Stephen Strittmatter von der Yale-Universität hatten eine Genexpressions-Analyse durchgeführt, um den Auslöser für ein ...
Yale School of Medicine Appoints Stephen Strittmatter, MD ...Academic Med
www.academic-med.com
— Stephen Strittmatter, MD, PhD, will assume the position of chair of the Department of Neuroscience and director of the Kavli Institute for ...
Alzheimer’s missing link found: Is a promising target for new drugs |...
www.myscience.org
Yale School of Medicine researchers have discovered a protein that is the missing link in the complicated chain of events that lead to Alzheimer's...
Unexpected Prion Link In Alzheimer's Disease - HUM-MOLGEN news
hum-molgen.org
news section of the international communication forum in human genetics hum-molgen
Richard Strittmatter
products.kitsapsun.com
He is survived by a brother, Stephen Strittmatter of Port Orchard; two nieces and a nephew, Anna Smith, Karla Strittmatter and Steve Holmdahl, ...
SEARCH FOR SCI CURE: Yale researcher aiming for chronic ...norcalsci.org › news › › search-for-s...
norcalsci.org
Stephen Strittmatter. The vast majority of research and clinical trials to find a cure for paralysis are focused on those with a new injury which ...
The Nogo TrapWings for Life World Run
www.wingsforlifeworldrun.com
— “It is,” says study initiator Stephen Strittmatter Stephen Strittmatter (left) is the initiator of the clinical trial, Prof.
Drug Restores Cells and Memories in Alzheimer's: Mouse Study -...
neurosciencenews.com
A new drug has proven effective at restoring memories and neural connections in mouse models of Alzheimer's disease. The new drug was originally developed as a...
Drug restores cells and memories in Alzheimer's mouse models
medicalxpress.com
"The drug completely erased evidence of Alzheimer's synapse damage and memory loss in mouse models of the disease," said Stephen Strittmatter, the Vincent Coates Professor of Neurology and senior author of the study appearing July 5 in the journal Cell Reports. Researchers such as Strittmatter have ...
Yale School of Medicine Neuroscientist receiv | EurekAlert!
www.eurekalert.org
Stephen Strittmatter, M.D., professor of neurology and neurobiology at Yale School of Medicine and an internationally recognized leader in ...
Alzheimer's missing link foundEurekAlert!
www.eurekalert.org
— ... this is the protein that may be most easily targeted by drugs," said Stephen Strittmatter, the Vincent Coates Professor of Neurology and ...
Repurposed experimental cancer drug restores brain function in mouse...
www.nih.gov
NIH-supported research enables clinical trial to explore treatment for most common form of dementia.
ReNetX Bio Receives $7M Commitment from Wings for Life to
www.globenewswire.com
The foundation's support is a testament to the promising research results from ReNetX Founder and Scientific Advisor Stephen Strittmatter, MD, PhD, Vincent Coates Professor of Neurology at Yale. His discovery of proteins which limit nerve fiber growth after injury, and subsequent development of a ...
ReNetX Bio launched to investigate neuro-regenerative technology -...
spinalnewsinternational.com
ReNetX Bio has been launched as a new company aiming to develop the neuro-restorative Nogo Receptor platform technology developed at Yale University, New Haven, USA, by Stephen Strittmatter. Strittmatter is scientific advisor to and co-founder of the new company. The new company launches with ...
Yale study finds drug that treats Alzheimer’s in mice
www.nhregister.com
NEW HAVEN — A newly discovered molecular compound may help stop the progress of...
Saracatinib, a Cancer Drug, Logs Early Success as an Alzheimer’s...
www.brightfocus.org
Good news from Yale—researchers there report early success using a still-experimental cancer drug known as saracatinib to treat Alzheimer’s disease in mice.
Yale neuroscientists prepared to help build “BRAIN” - Yale Daily News
yaledailynews.com
Yale researchers are poised to contribute to the national decade-long effort to map the human brain.
Nogo bremst das WachstumSpektrum der Wissenschaft
www.spektrum.de
— ... Martin Schwab vom Institut für Hirnforschung in Zürich und Stephen Strittmatter von der Yale University of Medicine in New Haven, ...
Neurodegeneration: Alzheimereiweiß schädigt über ein Prionproteinwww.spektrum.de › Medizin
www.spektrum.de
· Die Neurologen um Stephen Strittmatter hatten in ihrem Experiment beobachtet, dass künstlich erzeugte Oligomere des Amyloid-Beta-Proteins ...
Yale team finds dozens of genes that block regeneration of neuronswww.eurekalert.org › news-releases
www.eurekalert.org
· "This opens a new chapter in regeneration research," said Stephen Strittmatter, the Vincent Coates Professor of Neurology and professor of ...
Yale Scientist to Speak at Announcement of Report on Effects of...
news.yale.edu
Yale neurologist Stephen Strittmatter will participate in a news conference Monday, March 19 in Washington on the state of biomedical research in the United...
sortiert nach Relevanz / Datum